Watson: PharmaVitae Generics Profile

The original one-stop information shop

UK head office: +44 (0) 1494 771930 International answering service: US +1 (508) 861 0401 email:

Industry

Other Reports

Watson: PharmaVitae Generics Profile

Report

Watson: PharmaVitae Generics Profile is a marketing resource from Datamonitor, a leading provider of online data, analytic and forecasting platforms for key vertical sectors. It helps 5,000 of the world's largest companies profit from better, more timely decisions.

From:

$3800

Overview |

More publications

Introduction

This analysis examines the historical and forecast performance for Watson in the generic pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key branded drugs. An interactive data and analysis tool provides quantitative and qualitative information.

Scope

Highlights

Reasons to Purchase

Understand the impact of the Andrx acquisition on Watson's overall performance Benchmark Watson's performance against key rivals in the generic pharmaceutical sector Evaluate Teva's historical and forecast, branded and generic growth drivers and resistors

Report Details:

Publisher:

Datamonitor

Type:

Market Study - September 2007

Number of pages:

First Publication Date:

14/9/2007